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Potassium carbonate in poly (ethylene glycol-400) has been found to be a highly effective and efficient medium for the 
straight forward, convenient, one pot and green synthesis of diethyl/ethyl cyano-5-[substituted phenyl-2,3-dihydro-[1,3,4]-
thiadiazolidino - [2, 3-c] – [1, 2, 4]-triazol -2- yl] – malonate/acetate through intramolecular cyclo- elimination of Michael 
adducts formed between the reaction of 4-amino-5- substituted phenyl-3-mercapto-1,2,4-triazole 1 with diethyl-2-
(ethoxymethylene) malonate and ethyl -2-cyano-3-ethoxyacrylate respectively. The structures of all the new compounds 
have been elucidated using IR, 1H and 13C NMR, mass spectral data and elemental analyses. 
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Michael addition of nucleophiles to electron deficient 
alkenes is one of the most powerful and widely used 
synthetic tools for the formation of carbon-carbon and 
carbon-hetero bonds in organic chemistry1-4. Hetero 
Michael additions, viz aza-Michael, thia-Michael etc. 
are the most exploited organic reactions and are the 
mainstay of efficient synthetic tools for the 
construction of druggable heterocyclic scaffolds and 
natural products5-7. Construction of molecular 
architecture by two or more bond formation in one-
step operation via Michael reaction has been one of 
the current interest in synthetic organic chemistry8,9. 
Although reports on double Michael additions with 
cyclic and acyclic acrylates and enones are numerous, 
but with acrylates having electron withdrawing group 
at -carbon along with an ethoxy group at -carbon 
with heterocyclic amines are scare. The continual up 
surge in facile, convenient and nonpolluting synthetic 
procedure urges chemists to increase tools of their 
arsenal. The growing awareness of the pressing need 
for greener and more sustainable technologies has 
focus attention on the use of alternative reaction 
media that circumvent the problems associated with 
traditional volatile organic solvents. One such 
approach to address this challenge is the elimination 
or reduction of the threat of use of volatile organic 
solvents to achieve the most important goal of green 
chemistry. Poly (ethylene glycol), a biologically 
acceptable polymer used in drug delivery has been 
emerged as an alternative and interesting green 
reaction media in organic synthesis. It has replaced 
many other neotric solvents such as ionic liquid, 
super-carbon dioxide and micellar systems whose 
toxicological properties and biodegradability have not 
been established completely. Its unique properties 
such as thermal stability, cost effectiveness, 
commercial availability, non-volatility, reduced 
toxicity, ease of recyclability, non-halogenated nature 
and high polarity for solubilization with wide variety 
of organic solvents render PEG a designer solvent in 
organic synthesis. Although Michael addition 
reactions in various solvents have been accomplished 
but only few reports in PEG are currently known10-12. 
There have been reports on Michael addition 
reactions, catalysed by an in-expensive commercial 
compound, K2CO3 in various solvents
13-16, but in PEG 
are scare10. 
The high therapeutic properties of the compounds 
incorporating nitrogen heterocycles have encouraged 
the medicinal chemists to synthesize large number of 
novel therapeutic agents.  
Thiadiazoles are known to have wide spectrum of 
biological activities such as anti-bacterial17, 
pesticidal18-20, anti-fungal17 anti-tubercular21, carbonic 




anhydrase inhibitors22, anti-inflammatory23, 
analgesic23, anti-depressant24-26, anti-HIV and anti-
cancer activities. 
Triazoles have received considerable importance 
because of their wide biological applications. They 
exhibit antifungal27, anti-inflammatory28, anti-cancer29 
and anti-convulsant30 activities. These are less toxic 
than compounds like keto-conazole and miconazole 
due to their selective toxicity towards fungal target 
enzymes. Fluconazole is one of the potent triazole 
containing antifungal agent. 
The cyano group is a stable and useful functional 
group that can be transformed to various other 
functional groups such as acyl, carboxy, formyl, 
carbamoyl etc.31 The past seven decades has 
witnessed the transition of organic nitriles from a 
position of laboratory curiosities to that of large 
tonnage chemicals of commercial importance. On the 
other hand, reactions involving C-C bond formation 
are one of the mainstays in synthetic organic 
chemistry. The use of nitrile for C-C bond formation 
reactions occupies an important position in organic 
chemistry32-34. 
In the light of the above literature facts and 
abundance we report herein, thiadiazole and triazole 
derivatives through double Michael addition using 
potassium carbonate an effective and efficient catalyst 
(Scheme I). A plausible mechanism for the formation 
of titled 2, 3-dihydro-[2, 3-c] – [1, 2, 4]- triazole 
scaffold is given in Scheme II. The titled compounds 
by virtue of having thiadiazole and triazole moiety in 








activity. The structure of these compounds established 
by the IR,1H NMR, 13C NMR and elemental analysis. 
The required starting material 4-amino-5-substituted 
phenyl-3-mercapto-1, 2, 4-triazole 1 was prepared 
according to the reported methods20. 
 
Antimicrobial activity  
The antimicrobial of synthesized compounds 2a-d 
and 3a-d was determined in vitro against four 
bacterial strains. For this study, the test cultures of 
bacterial strains Escherichia coli, Salmonella typhii, 
Bacillus subtilis and Staphylococcus aureus were 
maintained in nutrient agar slants at 37°C. The 
antimicrobial activity of compounds against test 
bacteria was determined by agar well diffusion 
method35,36 using standard antibiotic ciprofloxacin as 
positive control and DMSO as negative control. All 








The result of present investigation showed that 
compounds 2b, 2c and 3c have promising activity 
against all the test organisms. 
Except 2a all the compounds showed moderate to 
good activity against Staphylococcus aures. Most of 
the other compounds were either weakly active or 
inactive against test organisms. Compounds 2b, 2c 
and 3c is found to be most effective against all test 
organisms (Table I). 
 
Fungicidal screening 
The fungicidal activity was evaluated against 
Cephalosporium saccharii and Helminthosporium 
oryzae by the usual agar-plate technique37 in Czapek’s a 
gas medium of 1000 ppm, 100 ppm, 10 ppm 
concentrations using Mancozeb M-45, a commercial 
fungicide, as standard. The compounds were tested 
either as solution or suspension in acetone-water 20:80 
(v/v) mixture. The standard solution or suspensions of 
different concentration of each compound viz 10000 
ppm, 1000 ppm and 100 ppm were prepared in acetone-
water 20:80 (v/v) mixture. 1 ml of each concentration of 
the tested compound was added separately to 
presterilized petri dishes containing 9 ml of sterilized 
Czapek’s agar medium to maintain the final 
concentrations of 1000 ppm, 100 ppm and 10 ppm. The 
compound was thoroughly mixed with the medium by 
rotating the plates on table top, thus swirling the 
contents. A fungal disk of 5 mm diameter cut out with 
the help of sterilized cork borer from the periphery of 
one weak old culture of test fungus already planted on 
the Czapek’s agar medium, was inoculated in the centre 
of each petri-dishes containing 9 ml of Czapek’s agar 
medium. The numbers of replications in each case were 
three. After 96 hr the diameter of fungal growth zone 
was measured. The results were expressed in terms of 
the percentage growth inhibition, by comparing with 
growth on control. Thus 
 





Where, C= diameter (in mm) of the fungal colony in 
control plate, T= diameter (in mm) of the fungal colony 
in treated plate. 
The antifungal data of compounds are listed in 
Table II. 
Among all the compounds, compound 2b and  
3c has good antifungal activity and the 
remaining compounds are displayed moderate 
antifungal activity. 
Table I — Zone of inhibition in mm at concentration 100 μg/mL 
Compd Bacillus subtilis Staphylococcus aureus Escherichia coli Salmonella typhii 
2a − 12 − − 
2b 31 24 28 27 
2c 24 22 21 22 
2d weak 15 weak − 
3a − 12 − − 
3b 10 12 − − 
3c 23 19 21 21 
3d − − weak − 
Ciprofloxacin 35 46 40 40 
 




Cephalosporium saccharii Heliminthosporium oryzae 
1000 ppm 100 ppm 10 ppm 1000 ppm 100 ppm 10 ppm 
2a 84 62 45 80 60 52 
2b 100 90 75 97 68 47 
2c 84 59 33 83 71 50 
2d 79 45 26 83 61 42 
3a 83 63 44 79 61 51 
3b 78 41 26 85 60 44 
3c 100 91 76 95 69 48 
3d 84 58 32 83 71 50 
Mancozeb M-45 100 72 58 100 86 58 





All the melting points were determined on a Cintex 
melting point apparatus and are uncorrected. All 
reagents were purchased commercially and used 
without further purification. IR spectra were recorded 
using KBr pellets on a perkin-Elmer BX series FT-IR 
spectrophotometer. The 1HNMR spectra were 
recorded in CD Cl3/DMSO-d6 on a varian Gemini  
300 MHz spectrometer. The 13CNMR spectra were 
recorded in CD Cl3/DMSO-d6 on a Jeol JNM 
spectrometer at 75.5 MHz chemical shifts are reported 
in δ, ppm using TMS as internal standard. Mass 
spectral measurements were carried out at 70ev by  
El method on a Jeol JMC-300 spectrometer. The 
homogeneity of the compounds was checked by TLC 
(silica gel, hexane/ethyl acetate). 
 
General procedure for synthesis of diethyl-5-
[substituted phenyl- 2, 3-dihydro-[1, 3, 4]-
thiadiazolidino-[2, 3-c]-[1, 2, 4]-triazol-2-yl]-
malonate (2a-d) 
To a mixture of diethyl ethoxyethylene malonate 
(2.0 m mol) and K2CO3 (0.15 m mol) in polyethylene 
glycol (5 mL) was added 4-amino-5- substituted 
phenyl -3-mercapto – 1, 2, 4-triazole (2.0 m mol) and 
reaction mixture was allowed to stir at 60°C for 2-3h. 
The progress of the reaction was monitored by TLC. 
After completion of the reaction the mixture was 
diluted with water and neutralized with 1 N HCl. The 
precipitate thus formed was filtered to give the 
product. The crude products (2a-d) was purified by 
column chromatography and characterized by 





Colourless solid yield 68% m.p. 180°C; IR: 3208  
(N-H), 3030 (C-H arom), 2914 (C-H aliph) 1702 
(C=O ), 1664 (C=N), 1592,1491 (phenyl ring), 1429 
(C=C) cm-1; 1H NMR (DMSO-d6): δ , 7.34-6.95 (m, 
5H, arom), 4.95 (t,1H,methyne proton of thiadiazole 
ring), 4.19-4.27 (q, 2H,OCH2), 3.22 (d,1H,methylene 
proton), 2.21(d,1H, NH proton of thiadiazole ring), 
1.43 (t,3H,CH3); 
13C NMR (δ ppm) : δ 14.1, 60.6, 
66.2, 124.7, 125.0, 125.7, 126.9, 129.2, 130.5, 156.5, 




2b: Yellow solid yield 74% m.p. 172°C IR: 3040  
(C-H arom), 1710 (C=O of pyrimidine ring), 1605 
(C=N), 1525 (phenyl ring stretching) cm-1; 1H NMR 
(DMSO-d6): δ 7.95-7.50 (m, 4H, arom), 4.75 (t,1H, 
CH proton), 4.13 (q, 2H, OCH2 proton), 3.66 (d, 1H, 
CH proton), 2.0 (d, 1H, NH proton), 1.29 (t, 3H, CH3 
proton); 13C NMR (δ ppm) : δ 14.3, 52.6, 124.3, 
127.3, 137.5, 148.7, 150.7, 166.6, 167.7, 168.6. MS 




2c: Colourless solid yield 76% m.p. 155°C IR: 3020 
(C-H arom), 1715 (C=O of pyrimidine ring), 1600 
(C=N), 1530 (phenyl ring) cm-1; 1H NMR (DMSO-
d6): δ 7.80-7.45 (m, 4H, arom), 4.75 (t,1H, CH 
proton), 4.18 (q, 2H, OCH2 proton), 3.64 (d, 1H, CH 
proton), 2.0 (d, 1H, NH proton), 1.29 (t, 3H, CH3 
proton); 13C NMR (δ ppm) : δ 14.6, 52.6, 61.8, 128.3, 
128.9, 129.5, 135.1, 151.4, 167.6, 169.8, MS (m/z) 




malonate 2d: Colourless solid yield 65% m.p. 165°C 
IR: 3030 (C-H arom), 1725 (C=O of pyrimidine ring), 
1610 (C=N), 1525 (phenyl ring) cm-1; 1H NMR 
(DMSO-d6): δ 7.77-7.46 (m, 3H, arom), 4.43(t,1H, 
CH proton), 4.14 (q, 2H, OCH2 proton), 3.60 (d, 1H, 
CH proton), 2.0 (d, 1H, NH proton), 1.29 (t, 3H, CH3 
proton); 13C NMR (δ ppm) : δ 14.3, 52.9, 61.3, 127.7, 
130.2, 130.9, 133.4, 135.9, 136.8, 151.4, 167.3, 167.9, 
168.2. MS (m/z) (M+) 429.01 (100%). 
 
General procedure for synthesis of ethyl cyano-
5-[substituted phenyl- 2, 3-dihydro-[1, 3, 4]-
thiadiazolidino-[3, 2-c]-[1, 2, 4]-triazol-2-yl]-
acetate, 3a-d 
To a mixture of ethyl-2-cyano-3-ethoxy acrylate  
(2.0 m mol) and K2CO3 (0.15 m mol) in polyethylene 
glycol (5 mL) was added 4-amino-5- substituted phenyl 
-3-mercapto – 1, 2, 4-triazole (2.0 m mol) and reaction 
mixture was allowed to stir at 60°C for 2-3h. The 
progress of the reaction was monitored by TLC. After 
completion of the reaction, the mixture was diluted with 
water neutralized with 1 N HCl. The precipitate thus 
formed was filtered to give the product. The crude 
products (3a-d) were purified by column 
chromatography and characterized by 1HNMR, 




3a: Colourless solid yield 60% m.p. 145°C IR: 3181 
 (N-H), 3096 (C-H arom), 2910 (C-H aliph), 2215 




(C≡N), 1688 (C=O), 1605 (C=N ), 1405 (C=C) cm-1; 
1H NMR (DMSO-d6): δ 8.31-7.45 (m, 5H, arom), 
4.96 (t,1H,methyne proton of thiadiazole ring), 4.24 
(q, 2H,OCH2), 3.56 (d,1H, methylene proton), 2.50 
(d,1H, NH proton of thiadiazole ring), 1.20(t,3H,CH3-
proton); 13C NMR (δ ppm) : δ 14.6, 48.8, 55.0, 99.3, 
113.7, 130.4, 126.8, 127.8, 149.6, 158.5, 168.0, 182.3. 




[3,2-c]-1,2,4-triazol-2-yl]-acetate 3b: Yellow solid 
yield 72% m.p. 164°C IR: 3035 (C-H arom), 2210 
(C≡N) 1725 (C=O of pyrimidine ring), 1615 (C=N) 
cm-1; 1H NMR (DMSO-d6): δ 7.85-7.43 (m, 3H, 
arom), 4.80 (t,1H, CH proton), 4.20 (q, 2H, OCH2 
proton), 3.61 (d, 1H, CH proton), 2.0 (d, 1H, NH 
proton), 1.29 (t, 3H, CH3 proton); 
13C NMR (δ ppm) : 
δ 14.2, 64.4, 115.9, 127.7, 130.2, 130.9, 133.4, 135.9, 





c]-1,2,4-triazol-2-yl]-acetate 3c: Colourless solid 
yield 72% m.p. 182°C IR: 3005 (C-H arom), 2210 
(C≡N), 1702 (C=O of pyrimidine ring), 1605 (C=N) cm-
1; 1H NMR (DMSO-d6): δ 7.90-7.45 (m, 4H, arom), 4.45 
(t,1H, CH proton), 4.18 (q, 2H, OCH2 proton), 3.74 (d, 
1H, CH proton), 2.0 (d, 1H, NH proton), 1.29 (t, 3H, 
CH3 proton); 
13C NMR (δ ppm) : δ 14.2, 37.8, 64.5, 
115.6, 128.4, 128.9, 129.5, 134.6, 151.4, 163.6, 167.6, 




c]-1,2,4-triazol-2-yl]-acetate 3d: Colourless solid 
yield 65% m.p. 152°C IR: 3010 (C-H arom), 2210 
(C≡N), 1702 (C=O of pyrimidine ring), 1605 (C=N) 
cm-1; 1H NMR (DMSO-d6): δ 7.70-7.30 (m, 4H, 
arom), 4.45 (t,1H, CH proton), 4.18 (q, 2H, OCH2 
proton), 3.74 (d, 1H, CH proton), 2.0 (d, 1H, NH 
proton), 1.29 (t, 3H, CH3 proton); 
13C NMR (δ ppm) : 
δ 14.2, 37.8, 64.5, 115.6, 127.3, 128.8, 129.5, 130.1, 
132.6, 138.5, 151.4, 163.6, 167.6, 168.3, MS (m/z) 
(M+) 349.02 (100%). 
 
Conclusion 
In the present investigation, a series of new 
heterocyles have been synthesized and screened for 
their antifungal and antimicrobial activity. The 
activity results reveal that the synthesized compounds 
possess moderate to good activity profiles. The 
insights gained in this study will be useful for 
development of newer anti-infective agents. 
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